In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents. (2018)
Attributed to:
Towards NanoMedicine Interventions for HIV/AIDS
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s40262-017-0557-x
PubMed Identifier: 28540638
Publication URI: http://europepmc.org/abstract/MED/28540638
Type: Journal Article/Review
Volume: 57
Parent Publication: Clinical pharmacokinetics
Issue: 2
ISSN: 0312-5963